Kane Biotech Inc. (CVE:KNE – Get Free Report)’s share price reached a new 52-week low on Thursday . The company traded as low as C$0.03 and last traded at C$0.04, with a volume of 89000 shares changing hands. The stock had previously closed at C$0.04.
Kane Biotech Price Performance
The stock has a market capitalization of C$5.82 million, a P/E ratio of -0.39 and a beta of 0.23. The business’s 50 day simple moving average is C$0.04 and its two-hundred day simple moving average is C$0.05. The company has a quick ratio of 0.39, a current ratio of 0.80 and a debt-to-equity ratio of -331.42.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Further Reading
- Five stocks we like better than Kane Biotech
- How to Invest in Insurance Companies: A Guide
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Joby and Archer Forge a New Strategic Chapter in the UAE
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Speculative Stocks to Sell Before the Bottom Drops Out
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
